LEADER 03629nam  22007815  450 
001 9910619286203321
005 20240429141601.0
010   $a9789811955952$b(electronic bk.)
010   $z9789811955945
024 7 $a10.1007/978-981-19-5595-2
035   $a(MiAaPQ)EBC7119922
035   $a(Au-PeEL)EBL7119922
035   $a(CKB)25179647300041
035   $a(OCoLC)1348480851
035   $a(DE-He213)978-981-19-5595-2
035   $a(PPN)265863155
035   $a(EXLCZ)9925179647300041
100   $a20221019d2022      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPlasmacytoid Dendritic Cells$b[electronic resource] /$fby Dipyaman Ganguly
205   $a1st ed. 2022.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2022.
215   $a1 online resource (170 pages)
311 08$aPrint version: Ganguly, Dipyaman Plasmacytoid Dendritic Cells Singapore : Springer,c2022 9789811955945 
320   $aIncludes bibliographical references.
327   $aChapter 1_Dendritic cells and the basic principles of immune functions -- Chapter 2_Discovery of a new dendritic cell -- Chapter 3_Hematopoietic origins of plasmacytoid dendritic cells -- Chapter 4_Molecular regulation of plasmacytoid dendritic cell identity -- Chapter 5_Type I interferon production by plasmacytoid dendritic cells -- Chapter 6_Tolerogenic functions of plasmacytoid dendritic cells -- Chapter 7_Plasmacytoid dendritic cells and infections -- Chapter 8_Plasmacytoid dendritic cells in autoimmunity and allergy -- Chapter 9_Plasmacytoid dendritic cells and metabolic disorders -- Chapter 10_ Plasmacytoid dendritic cells and cancer -- Chapter 11_Therapeutic targeting of plasmacytoid dendritic cells -- Chapter 12_Experimental methodology for plasmacytoid dendritic cells.
330   $aThis book provides a systematic review of the development, function, and patho-physiologic role of plasmacytoid dendritic cells (pDCs) in humans. The chapters of the book discuss the origin and discovery, hematopoietic development as well as molecular regulation of pDCs in the context of immune activation as well as immune tolerance. It also discusses the role of pDCs in human diseases, including infections, autoimmune/inflammatory diseases, cancers and metabolic disorders, and opportunities for pDC?targeting therapies in these varied clinical contexts. .
606   $aImmunology
606   $aCancer
606   $aNatural immunity
606   $aImmunologic diseases
606   $aAutoimmunity
606   $aInflammation
606   $aImmunology
606   $aCancers
606   $aInnate Immunity
606   $aImmunological Disorders
606   $aAutoimmunity
606   $aInflammation
606   $aCèl·lules dendrítiques$2thub
606   $aImmunologia$2thub
608   $aLlibres electrònics$2thub
615  0$aImmunology.
615  0$aCancer.
615  0$aNatural immunity.
615  0$aImmunologic diseases.
615  0$aAutoimmunity.
615  0$aInflammation.
615 14$aImmunology.
615 24$aCancers.
615 24$aInnate Immunity.
615 24$aImmunological Disorders.
615 24$aAutoimmunity.
615 24$aInflammation.
615  7$aCèl·lules dendrítiques
615  7$aImmunologia
676   $a616.079
700   $aGanguly$b Dipyaman$01262830
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910619286203321
996   $aPlasmacytoid Dendritic Cells$92954780
997   $aUNINA